Gunjan Shah Selected Research

Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)

3/2024

BEAM versus pharmacokinetics-directed BuCyVP16 conditioning for patients with peripheral T-cell lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gunjan Shah Research Topics

Disease

11	Multiple Myeloma 02/2024 - 10/2013
8	Neoplasms (Cancer) 01/2024 - 01/2013
5	Hematologic Neoplasms (Hematological Malignancy) 01/2024 - 03/2015
4	Infections 02/2024 - 01/2013
4	Lymphoma (Lymphomas) 09/2023 - 01/2020
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2023 - 03/2015
3	Residual Neoplasm 12/2022 - 06/2021
2	Neutropenia 02/2024 - 06/2021
2	Bone Marrow Failure Disorders 01/2024 - 01/2024
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 01/2023
2	cell-associated neurotoxicity 01/2023 - 01/2020
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 01/2020
2	Thrombocytopenia (Thrombopenia) 10/2013 - 01/2013
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 03/2024
1	Agammaglobulinemia (Hypogammaglobulinemia) 02/2024
1	Weight Gain 01/2024
1	Muscle Weakness 01/2024
1	Hyperglycemia 01/2024
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2024
1	Psychotic Disorders (Schizoaffective Disorder) 01/2024
1	Nausea 12/2023
1	Breakthrough Infections 11/2023
1	Osteonecrosis (Kienbock's Disease) 01/2023
1	Neurotoxicity Syndromes (Toxic Encephalopathy) 01/2023
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2023
1	Hodgkin Disease (Hodgkin's Disease) 10/2021
1	Exanthema (Rash) 06/2021
1	Cytokine Release Syndrome 01/2020
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/2015
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2015
1	Peripheral Nervous System Diseases (PNS Diseases) 10/2013
1	Diarrhea 10/2013
1	Amyloidosis 10/2013
1	Rectal Neoplasms (Rectal Cancer) 01/2013
1	Acute Kidney Injury (Acute Renal Failure) 01/2013

Drug/Important Bio-Agent (IBA)

4	Bortezomib (Velcade)FDA Link 02/2023 - 10/2013
4	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2020
3	Dexamethasone (Maxidex)FDA LinkGeneric 02/2023 - 01/2020
3	Lenalidomide (CC 5013)FDA Link 02/2023 - 03/2015
3	Proteasome InhibitorsIBA 06/2021 - 10/2013
2	carfilzomibIBA 02/2023 - 06/2021
2	pembrolizumabIBA 01/2023 - 10/2021
2	daratumumabIBA 12/2022 - 06/2021
2	Melphalan (Alkeran)FDA LinkGeneric 06/2021 - 01/2020
1	insulin receptor-related receptor (IRR)IBA 02/2024
1	B-Cell Maturation AntigenIBA 02/2024
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 02/2024
1	Prednisone (Sone)FDA LinkGeneric 01/2024
1	Alkylating AgentsIBA 01/2024
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 01/2024
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2023
1	Amifostine (Ethyol)FDA LinkGeneric 12/2023
1	VaccinesIBA 11/2023
1	cilgavimabIBA 11/2023
1	Monoclonal AntibodiesIBA 11/2023
1	cilgavimab and tixagevimab drug combinationIBA 11/2023
1	tixagevimabIBA 11/2023
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2023
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2023
1	Butyrates (Butyrate)IBA 12/2022
1	Vinorelbine (Navelbine)FDA LinkGeneric 10/2021
1	Gemcitabine FDA Link 10/2021
1	liposomal doxorubicin (Doxil)FDA Link 10/2021
1	Alanine Transaminase (SGPT)IBA 06/2021
1	axicabtagene ciloleucelIBA 01/2020
1	fludarabineIBA 01/2020
1	ixazomibIBA 01/2020
1	selinexorIBA 01/2020
1	tisagenlecleucelIBA 01/2020
1	Immunomodulating AgentsIBA 01/2020
1	Busulfan (Busulfex)FDA Link 01/2020
1	Cytotoxins (Cytolysins)IBA 01/2020
1	Thalidomide (Thalomid)FDA Link 03/2015
1	InterferonsIBA 03/2015
1	Alemtuzumab (Campath)FDA Link 03/2015
1	Bendamustine Hydrochloride FDA Link 03/2015
1	Dasatinib (BMS 354825)FDA Link 03/2015
1	Rituximab (Mabthera)FDA Link 03/2015
1	Imatinib Mesylate (Gleevec)FDA Link 03/2015
1	SteroidsIBA 01/2013
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2013

Therapy/Procedure

14	Therapeutics 03/2024 - 01/2013
6	Cell Transplantation 03/2024 - 12/2020
5	Hematopoietic Stem Cell Transplantation 01/2024 - 01/2019
2	Drug Therapy (Chemotherapy) 06/2021 - 01/2021
2	Transplantation 01/2020 - 01/2013
1	Cryotherapy (Therapy, Cold) 12/2023
1	Plant-Based Diet 12/2022
1	Radiotherapy 01/2020
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2020
1	Stem Cell Transplantation 01/2019
1	Investigational Therapies (Experimental Therapy) 03/2015
1	Subcutaneous Injections 10/2013
1	Drug Tapering 10/2013
1	Plasmapheresis 01/2013